sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - daganatellenes szerek - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
imjudo
astrazeneca ab - tremelimumab - carcinoma, hepatocellular - daganatellenes szerek - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.
neurontin 600 mg filmtabletta
pfizer kft. - gabapentin -
neurontin 800 mg filmtabletta
pfizer kft. - gabapentin -
sp 54 bevont tabletta
kéri pharma hungary kft. - pentozán-poliszulfát-nátrium -
lastet 100 mg lágy kapszula
euro nippon kayaku gmbh - etoposide -
lastet 25 mg lágy kapszula
euro nippon kayaku gmbh - etoposide -
lastet 50 mg lágy kapszula
euro nippon kayaku gmbh - etoposide -
magnesium-diasporal 100 szopogató tabletta
beaco bt. - a magnézium-citrát -
klabax 50 mg/ml granulátum belsőleges szuszpenzióhoz
ranbaxy uk ltd. - klaritromicin -